A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The new service delivers end-to-end support, managing every stage of an epigenomics project
The new functionality complements Parse’s existing Evercode immune products
The product delivers 100 percent of the Recommended Dietary Allowance (RDA) of three essential nutrients—Biotin, Vitamin C and Zinc
Subscribe To Our Newsletter & Stay Updated
